0000899243-18-006557.txt : 20180306
0000899243-18-006557.hdr.sgml : 20180306
20180306203208
ACCESSION NUMBER: 0000899243-18-006557
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180302
FILED AS OF DATE: 20180306
DATE AS OF CHANGE: 20180306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Campbell Paul
CENTRAL INDEX KEY: 0001657568
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 333-199861
FILM NUMBER: 18671678
MAIL ADDRESS:
STREET 1: BUILDING 4, TRIDENT PLACE
STREET 2: MOSQUITO WAY
CITY: HATFIELD, HERTFORDSHIRE
STATE: X0
ZIP: AL10 9UL
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mylan N.V.
CENTRAL INDEX KEY: 0001623613
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981189497
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BUILDING 4, TRIDENT PLACE, MOSQUITO WAY
CITY: HATFIELD, HERTFORDSHIRE
STATE: X0
ZIP: AL10 9UL
BUSINESS PHONE: 44 0 1707 853 000
MAIL ADDRESS:
STREET 1: BUILDING 4, TRIDENT PLACE, MOSQUITO WAY
CITY: HATFIELD, HERTFORDSHIRE
STATE: X0
ZIP: AL10 9UL
FORMER COMPANY:
FORMER CONFORMED NAME: New Moon B.V.
DATE OF NAME CHANGE: 20141028
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-02
0
0001623613
Mylan N.V.
MYL
0001657568
Campbell Paul
BUILDING 4, TRIDENT PLACE, MOSQUITO WAY
HATFIELD, HERTFORDSHIRE
X0
AL10 9UL
UNITED KINGDOM
0
1
0
0
See Remarks
Ordinary Shares
2018-03-03
4
M
0
831
0.00
A
17054
D
Ordinary Shares
2018-03-03
4
F
0
357
40.97
D
16697
D
Ordinary Shares
2018-03-03
4
M
0
220
0.00
A
220
I
By Spouse
Ordinary Shares
2018-03-03
4
F
0
75
40.97
D
145
I
By Spouse
Ordinary Shares
2018-03-04
4
X
0
480
0.00
A
17177
D
Ordinary Shares
2018-03-04
4
F
0
206
40.97
D
16971
D
Ordinary Shares
2018-03-04
4
X
0
190
0.00
A
335
I
By Spouse
Ordinary Shares
2018-03-04
4
F
0
65
40.97
D
270
I
By Spouse
Ordinary Shares
2018-03-04
4
M
0
1081
0.00
A
18052
D
Ordinary Shares
2018-03-04
4
F
0
530
40.97
D
17522
D
Ordinary Shares
2018-03-06
4
X
0
7030
11.18
A
24552
D
Ordinary Shares
2018-03-06
4
S
0
7030
44.01
D
17522
D
Ordinary Shares
2018-03-06
4
X
0
5766
12.15
A
23288
D
Ordinary Shares
2018-03-06
4
F
0
1621
43.23
D
21667
D
Ordinary Shares
318
I
By 401(k) Plan
Employee Stock Option - Right to Buy
40.97
2018-03-02
4
A
0
9681
0.00
A
2028-03-02
Ordinary Shares
9681
9681
D
Employee Stock Option - Right to Buy
40.97
2018-03-02
4
A
0
612
0.00
A
2028-03-02
Ordinary Shares
612
612
I
By Spouse
Restricted Stock Units
0.00
2018-03-02
4
A
0
5940
0.00
A
Ordinary Shares
5940
5940
D
Restricted Stock Units
0.00
2018-03-02
4
A
0
501
0.00
A
Ordinary Shares
501
501
I
By Spouse
Restricted Stock Units
0.00
2018-03-03
4
M
0
831
0.00
D
Ordinary Shares
831
1660
D
Restricted Stock Units
0.00
2018-03-03
4
M
0
220
0.00
D
Ordinary Shares
220
439
I
By Spouse
Restricted Stock Units
0.00
2018-03-04
4
X
0
480
0.00
D
Ordinary Shares
480
0
D
Restricted Stock Units
0.00
2018-03-04
4
X
0
190
0.00
D
Ordinary Shares
190
0
I
By Spouse
Performance Restricted Stock Units
0.00
2018-03-04
4
M
0
1081
0.00
D
Ordinary Shares
1081
0
D
Employee Stock Option - Right to Buy
11.18
2018-03-06
4
X
0
7030
0.00
D
2018-03-18
Ordinary Shares
7030
0
D
Employee Stock Option - Right to Buy
12.15
2018-03-06
4
X
0
5766
0.00
D
2009-03-05
Ordinary Shares
5766
11533
D
Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 3, 2017.
Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 4, 2015.
Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of the performance restricted stock units (PRSUs) granted on March 4, 2015.
Represents the acquisition of Mylan ordinary shares upon exercise of stock options granted on March 18, 2008.
Represents the acquisition of Mylan ordinary shares upon exercise of stock options granted on March 5, 2009.
Represents the delivery of ordinary shares to satisfy the exercise price associated with the exercise of stock options granted on March 5, 2009.
These options vest in three equal annual installments beginning on March 2, 2019 and expire on March 2, 2028.
Each RSU represents the right to receive one ordinary share of Mylan N.V. The RSUs vest in three equal annual installments beginning on March 2, 2019.
Each RSU represents the right to receive one ordinary share of Mylan N.V. 831 of the RSUs granted on March 3, 2017 vested on March 3, 2018, 830 will vest on March 3, 2019, and 830 will vest on March 3, 2020.
Each RSU represents the right to receive one ordinary share of Mylan N.V. 220 of the RSUs granted on March 3, 2017 vested on March 3, 2018, 219 will vest on March 3, 2019, and 220 will vest on March 3, 2020.
Each RSU represents the right to receive one ordinary share of Mylan N.V. 481 of the RSUs granted on March 4, 2015 vested on March 4, 2016, and 480 vested on each of March 4, 2017 and March 4, 2018.
Each RSU represents the right to receive one ordinary share of Mylan N.V. 190 of the RSUs granted on March 4, 2015 vested on March 4, 2016, 189 vested on March 4, 2017, and 190 vested on March 4, 2018.
Each PRSU represents the right to receive one ordinary share of Mylan N.V. The PRSUs were initially granted on March 4, 2015, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs fully vested on March 4, 2018.
The grant, of which these options were a part, vested in three equal installments beginning on March 18, 2009.
The grant, of which these options were a part, vested in three equal installments beginning on March 5, 2010.
Senior Vice President, Chief Accounting Officer & Corporate Controller
/s/ Kevin Macikowski, by power of attorney
2018-03-06